Heart rate variation analysis may not effectively detect sleep apnoeas in heart failure [2]

European Respiratory Journal

Volumn 28, Issue 2, 2006, Pages 457-458

  Teramoto, S ^a   Kume, H ^a   Yamaguchi, Y ^a   Yamamoto, H ^a   Ishii, M ^a   Ishii, T ^a   Ouchi, Y ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CARVEDILOL; TELMISARTAN;

CHEYNE STOKES BREATHING; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART RATE VARIABILITY; HUMAN; LETTER; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; SLEEP APNEA SYNDROME; SLEEP DISORDERED BREATHING;

FEMALE; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; MALE; SLEEP APNEA SYNDROMES;

EID: 33845500954     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.06.00044106     Document Type: Letter

References (10)

1. Vazir A, Dayer M, Hastings PC, et al. Can heart rate variation rule out sleep-disordered breathing in heart failure? Eur Respir J 2006; 27: 571-577.
2. Leung RS, Huber MA, Rogge T, Maimon N, Chiu KL, Bradley TD. Association between atrial fibrillation and central sleep apnea. Sleep 2005; 28: 1543-1546.
3. Schulz R, Eisele HJ, Seeger W. Nocturnal atrial fibrillation in a patient with obstructive sleep apnoea. Thorax 2005; 60: 174.
4. Garrigue S, Bordier P, Jais P, et al. Benefit of atrial pacing in sleep apnea syndrome. N Engl J Med 2002; 346: 404-412.
5. Simantirakis EN, Schiza SE, Chrysostomakis SI, et al. Atrial overdrive pacing for the obstructive sleep apnea-hypopnea syndrome. N Engl J Med 2005; 353: 2568-2577.
6. Karas M, Lacourciere Y, LeBlanc AR, et al. Effect of the renin-angiotensin system or calcium channel blockade on the circadian variation of heart rate variability, blood pressure and circulating catecholamines in hypertensive patients. J Hypertens 2005; 23: 1251-1260.
7. Mortara A, La Rovere MT, Pinna GD, Maestri R, Capomolla S, Cobelli F. Reversal of deteriorated fractal behavior of heart rate variability by beta-blocker therapy in patients with advanced congestive heart failure. J Cardiovasc Electrophysiol 2001; 12: 26-32.
8. Teramoto S, Ishii T, Matsuse T. Central sleep apnoeas in patients with Charcot-Marie-Tooth disease. Lancet 2001; 358: 70-71.
9. Teramoto S, Kume H, Matsuse T. Ambulatory blood pressure after sleep apnoea treatment. Lancet 2002; 360: 341.
10. Teramoto S, Matsuse T, Ouchi Y. Does the altered cardiovascular variability in association with obstructive sleep apnea contribute to development of cardiovascular disease in patients with obstructive sleep apnea syndrome? Circulation 1999; 100: e136-e137.